North America Breast Reconstruction Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology, Type; Placement, Procedure

Inframammary Segment has the Largest Share of Technology in the North America Breast Reconstruction Market during 2021-2028

According to a new market research study on “North America Breast Reconstruction Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Technology, Type, Placement and Procedure,” is expected to reach US$ 482.1 million by 2028 from US$ 312.2 million in 2021. The market is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The report provides trends prevailing in the North America breast reconstruction market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the high prevalence of breast cancer and new product launches and FDA approvals are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the low awareness regarding reimbursement policies.

The COVID-19 pandemic has impacted breast surgeries also in a pervasive manner. The sudden situation has stimulated breast and plastic surgeons, healthcare decision-makers, and policymakers, who have met with the need to expeditiously implement containment measures to mitigate the impact of the COVID-19 pandemic. Moreover, on March 13th, 2020, the American College of Surgeons (ACS) suggested that hospitals, health institutions, and surgeons across the nation reduce, postpone or cancel electively scheduled operations, including breast reconstruction procedures. The surgeries were canceled to maximize bed space, maintain personal protective equipment, and reduce the risk of transmission amongst patients and providers. Furthermore, the COVID-19 pandemic has undeniably introduced even more panic and fear into the previously anxiety-provoking situation of a breast cancer diagnosis. As per the report published by Anticancer Research in 2021, nearly half (44.2%) of the patients showed that breast reconstruction was not occurring at their institutions during the pandemic, whether that was by a delay of all oncologic treatment hormone/chemotherapy alone or mastectomy alone. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges. Moreover, the shift of priorities from breast reconstruction to coronavirus diagnosis and treatment devices are leading to a decline in breast reconstruction, leading to a decrease in market growth up to the certain extent.

The market for breast reconstruction market is segmented into technology, type, placement, and procedure. Based on technology, the breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical. In 2020, the inframammary by technology segment accounted for the largest share of the market. Growth of this segment is attributed to rising emphasis on aesthetic appearance and rising number of product launches. However, peri-areolar technology segment is estimated to register the highest CAGR during the forecast period.

Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), Sientra Inc. GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, HANSBIOMED CO. LTD, IDEAL IMPLANT INCORPORATED, Establishment Labs S.A. and Groupe Sebbin SAS are among the leading companies in the North America breast reconstruction market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2020, AbbVie announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.

The report segments the North America Breast Reconstruction market as follows:

By Technology

• Inframammary
• Peri-Areolar
• Trans-Axillary
• Transumbilical

By Type

• Breast Implants
• Implants accessories

By Placement

• Dual Plane Insertion
• Subglandular Insertion
• Submuscular Insertion

By Procedure

• Immediate Procedures
• Delayed Procedures
• Revision Procedures

By Country

• North America
• US
• Canada
• Mexico

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America breast reconstruction market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the North America breast reconstruction market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the breast reconstruction market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution